Please assess the completion status of the following clinical trial:

Trial Title: Implant Supported Oral Appliance Treatment of OSA

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~This trial will recruit 10 patients with an objective diagnosis of obstructive sleep apnea who are not naïve to treatment. The inclusion criteria are:~* Currently receive or have previously received successful OSA treatment with an OAm;~* Age 25 - 65 years old, who are able to freely provide informed consent;~* Body Mass Index (BMI) ≤ 35;~* Apnea-Hypopnea Index (AHI) within the range 5≤AHI≤50 documented with polysomnography in the last 2 years \*\*\*OR\*\*\*~* Respiratory Disturbance Index (RDI) within the range 20 ≤ RDI ≤ 50 documented with Level III portable sleep test \*\*\*OR\*\*\*~* Oxygen Desaturation Index (ODI) ≥ 10~Exclusion Criteria:~The patient is excluded if it meets any of the following criteria:~* Extensive periodontal disease;~* Bleeding disorder;~* Bone metabolic disorder~* Immunocompromised~* Diabetes mellitus~* Xerostomia~* Titanium allergy~* Insufficient vertical opening to accommodate treatment with OAm;~* Pregnancy (if a participant becomes pregnant during the trial, the participant will be withdrawn from the study).~* Uncontrolled congestive heart failure (defined as a prior clinical diagnosis, an ejection cut-off of 40% or clinical sign in the opinion of a primary care physician or cardiologist) that makes it unsafe in the opinion of the investigators for the subject to participate in the trial;~* Coronary artery disease unless stable for at least 6 months and considered by the investigators to have a stable disease;~* Any history of angina, myocardial infarction or stroke;~* Any history of major depressive disorder along with current moderate-severe disease;~* Active cancer management (unless in remission for more than 1 year);~* Known renal failure (with need for dialysis)

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Treatment Group (Type: EXPERIMENTAL): Participants will be treated with a novel experimental implant supported mandibular advancement oral appliance, which uniquely attaches to orthodontic mini implants (OMIs) in the jaw. Participants will be fitted with OMIs per standard clinical practice prior to treatment with the novel oral appliance.

Based on this trial design, predict the completion outcome and termination type (if applicable).